Literature DB >> 10951156

Erythema elevatum diutinum--evidence for disease-dependent leucocyte alterations and response to dapsone.

J Grabbe1, N Haas, A Möller, B M Henz.   

Abstract

Erythema elevatum diutinum (EED) is a type of leucocytoclastic vasculitis of unknown aetiology. We report a patient with unusually widespread and disabling EED that had been unresponsive to corticosteroids and antibiotics, but resolved on dapsone. Biopsies of fresh lesions showed typical features of leucocytoclastic vasculitis, with prominent neutrophil infiltration, marked expression of the beta(2)-integrins CR3 and LFA-1, and increased mast cell numbers. Older lesions exhibited granulation tissue and fibrosis, macrophages were more dominant, beta(2)-integrins were expressed less markedly, and mast cell numbers were lower. In vitro chemotaxis of the patient's peripheral blood neutrophils prior to treatment showed increased random migration and directed migration towards interleukin-8 (by 424%), but a profoundly decreased responsiveness towards the bacterial peptide analogue N-formyl-methionyl-leucyl-phenylalanine (fMLP) (by 98%). These values returned to normal after dapsone treatment and clinical improvement 5 months later. These findings support the concept that in EED, activation via cytokines such as interleukin-8 allows a selective recruitment of leucocytes to tissue sites, while immune complexes and bacterial peptides sustain the persistent local inflammatory infiltrate and the leucocytoclastic vasculitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951156     DOI: 10.1046/j.1365-2133.2000.03673.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  [Refractory cutaneous necrotizing vasculitis. Successful sulfone therapy].

Authors:  H Seybold; M Simon; G Schuler; M Lüftl
Journal:  Hautarzt       Date:  2006-01       Impact factor: 0.751

Review 2.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

3.  Erythema elevatum diutinum in systemic lupus erythematosus.

Authors:  Yung Chan; Chi Chiu Mok; William Yuk Ming Tang
Journal:  Rheumatol Int       Date:  2010-07-23       Impact factor: 2.631

Review 4.  A comprehensive insight into the anti-inflammatory properties of dapsone.

Authors:  Mina Khalilzadeh; Maryam Shayan; Sina Jourian; Mohammad Rahimi; Mohammad Sheibani; Ahmad Reza Dehpour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-20       Impact factor: 3.195

5.  Primary Cutaneous Small Vessel Vasculitis.

Authors:  James P. Russell; Roger H. Weenig
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

6.  Erythema elevatum diutinum: an atypical presentation.

Authors:  Martha Elena García-Meléndez; Sylvia A Martínez-Cabriales; Kristian Eichelmann; Minerva Gómez-Flores; Jorge Ocampo-Candiani
Journal:  Am J Med Sci       Date:  2015-04       Impact factor: 2.378

7.  A rare case of erythema elevatum diutinum presenting as diffuse neuropathy.

Authors:  Giang Huong Nguyen; Emily L Guo; David Norris
Journal:  JAAD Case Rep       Date:  2016-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.